Biofilm formation by group A streptococci: Is there a relationship with treatment failure?

Joslyn Conley, Merle E. Olson, Linda S. Cook, Howard Ceri, Van Phan, H. Dele Davies

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Group A streptococcus (GAS) is the primary cause of bacterial pharyngitis in children and adults. Up to one-third of patients treated for GAS pharyngitis fail to respond to antibiotic therapy. The objective of this cohort study was to evaluate GAS biofilm formation as a mechanism for antibiotic treatment failure using previously collected GAS isolates and penicillin treatment outcome data. The minimum biofilm eradication concentration (MBEC) assay device was used to determine the biofilm-forming capabilities, efficiencies, and antibiotic susceptibilities of GAS isolates. The MBECs and MICs of several antibiotics for GAS were determined. All 99 GAS isolates available for this study formed biofilms, with various efficiencies. Antibiotic MBECs were consistently higher than MICs for all of the GAS isolates. MBECs indicated penicillin insensitivity in 60% of GAS isolates, producing the first report of in vitro GAS insensitivity to penicillin. Using MBECs to predict penicillin treatment failure had better sensitivity (56%) but lower specificity (36%) than the sensitivity (0%) and specificity (100%) when MICs were used. However, the positive predictive value of the MBEC was superior to that of the MIC (56 versus 0%), while the negative predictive values (42 and 47%) were similar. More studies are needed to understand the roles of biofilms and the MBEC assay in predicting GAS treatment failure. In addition, further investigations are necessary to determine if non-biofilm-forming strains of GAS exist and the roles of in vivo monospecies and multispecies biofilms in streptococcal pharyngitis treatment failure.

Original languageEnglish (US)
Pages (from-to)4043-4048
Number of pages6
JournalJournal of clinical microbiology
Volume41
Issue number9
DOIs
StatePublished - Sep 1 2003

Fingerprint

Biofilms
Streptococcus
Treatment Failure
Penicillins
Pharyngitis
Anti-Bacterial Agents
Cohort Studies
Sensitivity and Specificity
Equipment and Supplies

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Biofilm formation by group A streptococci : Is there a relationship with treatment failure? / Conley, Joslyn; Olson, Merle E.; Cook, Linda S.; Ceri, Howard; Phan, Van; Davies, H. Dele.

In: Journal of clinical microbiology, Vol. 41, No. 9, 01.09.2003, p. 4043-4048.

Research output: Contribution to journalArticle

Conley, Joslyn ; Olson, Merle E. ; Cook, Linda S. ; Ceri, Howard ; Phan, Van ; Davies, H. Dele. / Biofilm formation by group A streptococci : Is there a relationship with treatment failure?. In: Journal of clinical microbiology. 2003 ; Vol. 41, No. 9. pp. 4043-4048.
@article{a95179ca7089497e9d85e17ab2060082,
title = "Biofilm formation by group A streptococci: Is there a relationship with treatment failure?",
abstract = "Group A streptococcus (GAS) is the primary cause of bacterial pharyngitis in children and adults. Up to one-third of patients treated for GAS pharyngitis fail to respond to antibiotic therapy. The objective of this cohort study was to evaluate GAS biofilm formation as a mechanism for antibiotic treatment failure using previously collected GAS isolates and penicillin treatment outcome data. The minimum biofilm eradication concentration (MBEC) assay device was used to determine the biofilm-forming capabilities, efficiencies, and antibiotic susceptibilities of GAS isolates. The MBECs and MICs of several antibiotics for GAS were determined. All 99 GAS isolates available for this study formed biofilms, with various efficiencies. Antibiotic MBECs were consistently higher than MICs for all of the GAS isolates. MBECs indicated penicillin insensitivity in 60{\%} of GAS isolates, producing the first report of in vitro GAS insensitivity to penicillin. Using MBECs to predict penicillin treatment failure had better sensitivity (56{\%}) but lower specificity (36{\%}) than the sensitivity (0{\%}) and specificity (100{\%}) when MICs were used. However, the positive predictive value of the MBEC was superior to that of the MIC (56 versus 0{\%}), while the negative predictive values (42 and 47{\%}) were similar. More studies are needed to understand the roles of biofilms and the MBEC assay in predicting GAS treatment failure. In addition, further investigations are necessary to determine if non-biofilm-forming strains of GAS exist and the roles of in vivo monospecies and multispecies biofilms in streptococcal pharyngitis treatment failure.",
author = "Joslyn Conley and Olson, {Merle E.} and Cook, {Linda S.} and Howard Ceri and Van Phan and Davies, {H. Dele}",
year = "2003",
month = "9",
day = "1",
doi = "10.1128/JCM.41.9.4043-4048.2003",
language = "English (US)",
volume = "41",
pages = "4043--4048",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "9",

}

TY - JOUR

T1 - Biofilm formation by group A streptococci

T2 - Is there a relationship with treatment failure?

AU - Conley, Joslyn

AU - Olson, Merle E.

AU - Cook, Linda S.

AU - Ceri, Howard

AU - Phan, Van

AU - Davies, H. Dele

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Group A streptococcus (GAS) is the primary cause of bacterial pharyngitis in children and adults. Up to one-third of patients treated for GAS pharyngitis fail to respond to antibiotic therapy. The objective of this cohort study was to evaluate GAS biofilm formation as a mechanism for antibiotic treatment failure using previously collected GAS isolates and penicillin treatment outcome data. The minimum biofilm eradication concentration (MBEC) assay device was used to determine the biofilm-forming capabilities, efficiencies, and antibiotic susceptibilities of GAS isolates. The MBECs and MICs of several antibiotics for GAS were determined. All 99 GAS isolates available for this study formed biofilms, with various efficiencies. Antibiotic MBECs were consistently higher than MICs for all of the GAS isolates. MBECs indicated penicillin insensitivity in 60% of GAS isolates, producing the first report of in vitro GAS insensitivity to penicillin. Using MBECs to predict penicillin treatment failure had better sensitivity (56%) but lower specificity (36%) than the sensitivity (0%) and specificity (100%) when MICs were used. However, the positive predictive value of the MBEC was superior to that of the MIC (56 versus 0%), while the negative predictive values (42 and 47%) were similar. More studies are needed to understand the roles of biofilms and the MBEC assay in predicting GAS treatment failure. In addition, further investigations are necessary to determine if non-biofilm-forming strains of GAS exist and the roles of in vivo monospecies and multispecies biofilms in streptococcal pharyngitis treatment failure.

AB - Group A streptococcus (GAS) is the primary cause of bacterial pharyngitis in children and adults. Up to one-third of patients treated for GAS pharyngitis fail to respond to antibiotic therapy. The objective of this cohort study was to evaluate GAS biofilm formation as a mechanism for antibiotic treatment failure using previously collected GAS isolates and penicillin treatment outcome data. The minimum biofilm eradication concentration (MBEC) assay device was used to determine the biofilm-forming capabilities, efficiencies, and antibiotic susceptibilities of GAS isolates. The MBECs and MICs of several antibiotics for GAS were determined. All 99 GAS isolates available for this study formed biofilms, with various efficiencies. Antibiotic MBECs were consistently higher than MICs for all of the GAS isolates. MBECs indicated penicillin insensitivity in 60% of GAS isolates, producing the first report of in vitro GAS insensitivity to penicillin. Using MBECs to predict penicillin treatment failure had better sensitivity (56%) but lower specificity (36%) than the sensitivity (0%) and specificity (100%) when MICs were used. However, the positive predictive value of the MBEC was superior to that of the MIC (56 versus 0%), while the negative predictive values (42 and 47%) were similar. More studies are needed to understand the roles of biofilms and the MBEC assay in predicting GAS treatment failure. In addition, further investigations are necessary to determine if non-biofilm-forming strains of GAS exist and the roles of in vivo monospecies and multispecies biofilms in streptococcal pharyngitis treatment failure.

UR - http://www.scopus.com/inward/record.url?scp=0041419116&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0041419116&partnerID=8YFLogxK

U2 - 10.1128/JCM.41.9.4043-4048.2003

DO - 10.1128/JCM.41.9.4043-4048.2003

M3 - Article

C2 - 12958223

AN - SCOPUS:0041419116

VL - 41

SP - 4043

EP - 4048

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 9

ER -